Alternately, there are data on lung cancer showing that low-PD-L1 copy-number tumors display reduced PD-L1 expression, reduced PD-L1 tumor cell staining, and an immunologic cold tumor microenvironment, and could thus possibly lead to less response to immunotherapy [90]. This evidence concerns the gene CD274 and neoplasm.